The Complete Appeal Guide for CPT 77067: Screening Mammography

Introduction

CPT 77067 is a routine screening mammogram of both breasts. It is not the code for 3D mammography on its own: screening tomosynthesis is reported with the add-on code 77063 together with 77067 (CMS NCCI Policy Manual, Chapter IX). Diagnostic mammograms use different codes: 77065 for one breast and 77066 for both. When a 77067 claim denies, check how the screening, tomosynthesis and diagnostic codes were combined on the claim before you build an appeal.

Despite the proven clinical benefits of CPT 77067, denials remain frustratingly common across all major payers. They often come from coding, frequency or eligibility problems, or from how the 3D add-on was billed, rather than from any doubt about the value of screening. The financial impact is substantial, and denials can quickly accumulate to significant revenue losses for healthcare practices.

This comprehensive guide provides the exact strategies, documentation requirements, and payer-specific tactics needed to successfully appeal CPT 77067 denials. Whether you're dealing with Medicare's screening rules or a commercial payer's policy, it covers what to check and what to send.

Common Denial Reasons

Understanding the most frequent denial patterns for CPT 77067 is crucial for both prevention and successful appeals. Here are the seven most common denial reasons across all payers:

1. Medical Necessity Questions

Screening mammography is a routine preventive service, and Medicare covers it on a set schedule, so a medical necessity denial on 77067 usually points to something else on the claim, such as a diagnosis code that does not describe a screening or a frequency edit. When the denied line is the add-on tomosynthesis code (77063), the plan may be applying a separate policy on 3D screening, so pull its current policy on breast tomosynthesis before you appeal.

2. Duplicate Service Claims

Screening and diagnostic mammograms are not normally done on the same day. When they are, Medicare requires modifier GG on the diagnostic code (77065 or 77066) and modifier 59 or XU on the screening code (CMS NCCI Policy Manual, Chapter IX). Without those modifiers, one of the two services is likely to deny as a duplicate. Commercial plans may follow the same convention or set their own; check the payer's billing policy.

3. Missing or Inadequate Documentation

For a screening study, the record should show that the patient had no symptoms and give the date of the last screening. Medicare does not require a physician's order for a screening mammogram, although it does for a diagnostic one (42 CFR 410.34). Commercial plans may have their own order or referral rules.

4. Age-Related Restrictions

Screening coverage is tied to age. Medicare pays for one baseline screening mammogram between ages 35 and 39 and, from age 40, one screening each year once 11 full months have passed after the month of the last one (42 CFR 410.34). Commercial plans set their own age and interval rules; check the member's benefits.

5. Frequency Limitations

A screening billed before the plan's interval has passed will deny. For Medicare, count 11 full months after the month of the last screening. If the patient had a new symptom or finding, the study was probably diagnostic and should have been coded that way, which is a corrected claim rather than an appeal.

6. Prior Authorization Requirements

Screening mammography is not usually on authorization lists, so check a denial for missing authorization against the plan's published list for the date of service. If the service was not on the list, say so in the appeal and attach the list.

7. Billing Modifier Issues

77067 already covers both breasts. The modifier rules that matter most for this code are the same-day screening and diagnostic rules described in reason 2.

Payer-Specific Requirements

Aetna

Pull Aetna's current medical policy on mammography and breast tomosynthesis and confirm the member's screening benefit (age and interval) for the plan on the claim. For an Aetna Medicare Advantage member, the plan must cover what Traditional Medicare covers, so Medicare's screening schedule is the minimum (42 CFR 422.101).

Appeal focus:

• Show that the study was a screening of a patient with no symptoms
• Give the date of the last screening and the patient's age
• If 77063 was billed, show that it was paired with 77067
• Quote the policy section the claim meets

Anthem Elevance Health

Anthem operates Blue Cross Blue Shield plans in some states, so the policy that applies depends on the member's state and product. Pull the current Anthem medical policy or clinical guideline on breast imaging for that plan, and check whether it treats 3D screening (77063) separately from the 2D screening mammogram (77067).

Appeal focus:

• State the screening indication, the patient's age and the date of the last screening
• If breast density or other risk factors matter under the policy, attach the report that documents them
• Ask for the specific policy citation if the denial does not give one

Blue Cross Blue Shield

Blue Cross Blue Shield plans are independent companies, and each sets its own medical policy. Identify the plan from the member's ID card, pull that plan's current policy on screening mammography and tomosynthesis, and quote it in the appeal. If the patient is covered by a Blue plan in another state, ask your local plan which plan's policy governs the claim.

Appeal focus:

• Match the documentation to the plan's written criteria, point by point
• Include the breast density report when the policy addresses density
• Request the policy citation if the denial does not give one

Cigna

Pull Cigna's current coverage policy on breast imaging and check the member's preventive benefit. Confirm the product type on the ID card, because the rules and the appeal route differ between employer plans, individual plans and government-program plans.

Appeal focus:

• Build the appeal around the policy criteria the claim meets
• Use national screening guidelines as support, not as a substitute for the policy
• Check the coding (77067 alone, or 77067 with 77063) against the policy

Humana

For a Humana Medicare Advantage member, the plan must cover screening mammography at least as Traditional Medicare does (42 CFR 422.101), and appeals follow the Medicare Advantage route: plan reconsideration, then the Independent Review Entity. For other Humana products, pull the current Humana coverage policy for breast imaging.

Appeal focus:

• Confirm the plan type before you write the appeal
• For Medicare Advantage, cite Medicare's screening rules and show the study met them
• Check any authorization or network rule the plan applies beyond Medicare's

Medicare Traditional

Coverage rules:
Medicare pays for one baseline screening mammogram for a woman aged 35 through 39 and, from age 40, one screening each year once 11 full months have passed after the month of the last one. A physician's order is not required for a screening mammogram, though it is for a diagnostic one (42 CFR 410.34). Screening tomosynthesis is billed as add-on 77063 with 77067, and a same-day screening and diagnostic pair needs modifier GG on the diagnostic code and 59 or XU on the screening code (CMS NCCI Policy Manual, Chapter IX).

Before appealing a Medicare denial:

• Confirm the patient's age and count the months since the last screening
• Check that the diagnosis code describes a screening, not a symptom
• Check the pairing of 77063 with 77067 and the modifiers on any same-day diagnostic study
• If the screening was simply too early, an appeal will not change that; check whether the study was actually diagnostic and should be corrected

Molina Healthcare

Molina offers Medicaid managed care, Medicare and Marketplace plans, so the rules depend on the product and, for Medicaid, the state. Pull the Molina policy for the member's state and product, and check whether the state's Medicaid program sets its own age or interval rules for screening mammography.

Appeal focus:

• Cite the state Medicaid rule or plan policy the claim meets
• Follow the appeal route and deadline in the plan's provider manual for that state
• For a Molina Medicare member, apply Medicare's screening rules

UnitedHealthcare

Pull UnitedHealthcare's current medical or reimbursement policy on breast imaging for the member's product (employer, individual, Medicare Advantage or Medicaid). Quote the specific criteria in the appeal and show where the record meets each one. For a Medicare Advantage member, Medicare's screening schedule is the minimum.

Appeal focus:

• Address every criterion in the policy, not only the one cited in the denial
• Check the coding and modifiers against the reimbursement policy as well as the medical policy
• Attach the prior screening dates

Required Documentation Checklist

Successful CPT 77067 appeals require comprehensive documentation. Use this checklist to ensure you have all necessary components:

Patient Information

• ☐ Patient age and the member's screening benefit (Medicare: one baseline at 35 to 39, then yearly from 40)
• ☐ Insurance eligibility confirmation
• ☐ Previous mammography history and dates
• ☐ Current asymptomatic status documentation

Clinical Documentation

• ☐ The order, if the payer requires one (Medicare does not for a screening study), and whether 3D imaging (77063) was also performed
• ☐ Risk factor assessment (family history, genetic factors, breast density)
• ☐ Clinical notes supporting screening indication
• ☐ Documentation ruling out diagnostic indications

Procedural Documentation

• ☐ Radiologist report for the screening, covering the tomosynthesis images if 77063 was billed
• ☐ Technical component documentation
• ☐ Bilateral procedure confirmation
• ☐ Equipment specifications and accreditation

Administrative Requirements

• ☐ Correct CPT 77067 coding
• ☐ Appropriate modifiers when required
• ☐ Date of service accuracy
• ☐ Provider credentialing verification

Sample Appeal Arguments

Argument 1: Screening Performed Within the Covered Schedule

"The [date] study was a routine screening mammogram of both breasts (CPT 77067) for a patient aged [age] with no breast symptoms. Her last screening mammogram was on [date], [number] full months earlier, which meets the plan's screening interval of [interval, citing the plan document or policy]. No symptoms or findings were documented before the study, and the diagnosis code [code] reflects a screening encounter. The service is a covered preventive benefit under [plan document or policy section], and we ask that the claim be reprocessed and paid."

Argument 2: Screening Tomosynthesis Billed as an Add-On

"The claim reports screening tomosynthesis with add-on code 77063 together with the screening mammogram, CPT 77067, which is how 3D screening is reported. [If the denial treats 77063 as a duplicate: 77063 describes only the tomosynthesis portion of the study and is reported with 77067, not instead of it, so the two codes do not duplicate each other.] [If the plan's policy covers 3D screening: Your policy [name, number, date] covers screening tomosynthesis for [criteria], and this patient meets those criteria because [facts from the record].]"

Argument 3: Same-Day Screening and Diagnostic Studies

"The patient's screening mammogram (CPT 77067) was followed the same day by a diagnostic mammogram ([77065 or 77066]) because [the screening images showed a finding that needed further views / the patient reported a new symptom at the visit]. These are two separate services with separate indications. The diagnostic study was reported with modifier GG and the screening study with modifier [59 or XU], [the coding Medicare requires when both are performed on the same day / the coding your billing policy [name, number] requires]. The reports for both studies are attached."

Argument 4: Patient-Specific Need for 3D Screening

"For this patient, screening tomosynthesis (77063) was added to the screening mammogram (77067) because of [specific risk factors or history, such as dense breast tissue documented on the prior report]. [State why 2D images alone were not sufficient for this patient, and cite the plan's policy criteria for 3D screening that she meets.] The decision was consistent with [the guideline or policy you rely on], and the supporting reports are attached."

Filing Deadlines

Understanding appeal deadlines is crucial for CPT 77067 denial reversals:

Commercial Payers

• Member appeal: ACA-compliant and ERISA group health plans must give the member (or an authorized representative, often the provider) at least 180 days from the adverse benefit determination to file an internal appeal
• Provider appeal under your contract: the participation contract sets the window, and windows vary (commonly 60 to 180 days, sometimes 365); check the contract and the denial notice
• Second level: plans that offer a second internal level set their own deadline; the first-level decision letter states it
• External review: under the federal process, request it within 4 months of the final internal denial; state processes vary. Standard decisions come within 45 days, expedited within 72 hours

Medicare Traditional

• Redetermination (MAC): within 120 days of receiving the initial determination; receipt is presumed 5 days after the notice date
• Reconsideration (Qualified Independent Contractor): within 180 days of receiving the redetermination
• ALJ hearing, Medicare Appeals Council, federal court: 60 days each; the ALJ and federal court levels have amount-in-controversy thresholds that change every year

Medicare Advantage

• Plan reconsideration: the enrollee, or a non-contracted provider with a waiver of liability, requests it within 65 days of the notice. Standard pre-service decisions come within 30 days, payment decisions within 60 days, expedited within 72 hours
• Independent Review Entity: if the plan upholds its denial, the case is forwarded automatically; you do not file it
• Contracted providers: payment disputes follow your contract with the plan

Medicaid/Molina

• State-specific timeframes: appeal windows vary by state and by managed care plan; check the denial notice and the plan's provider manual

Critical Tips:

• File appeals as quickly as possible; don't wait until deadlines approach
• Document all submission dates and methods
• Request appeal acknowledgment from payers
• Consider expedited review for urgent clinical situations

When to Request External Review

External review should be considered for CPT 77067 denials in these situations:

Clinical Scenarios

• Clear medical necessity with appropriate documentation
• Denial contradicts established medical evidence
• Patient-specific factors strongly support tomosynthesis use
• Payer policy appears to contradict evidence-based guidelines

Administrative Situations

• Multiple internal appeal denials despite strong documentation
• Inconsistent coverage decisions from the same payer
• Policy interpretation disputes
• Suspected coverage discrimination

Strategic Considerations

• External review covers medical judgment decisions, such as medical necessity, after the final internal denial; a coding error, such as a diagnostic study billed as a screening, is usually fixed faster with a corrected claim
• The reviewer is independent of the plan and reviews the claim fresh, without being bound by the plan's earlier decisions
• A decision binds that claim only; it is not precedent for other claims
• For a recurring denial pattern, raise it with the payer's provider relations contact as well as appealing each claim

Preparation for External Review

• Compile comprehensive clinical documentation
• Include peer-reviewed literature supporting tomosynthesis use
• Provide detailed medical necessity argument
• Consider expert clinical opinions for complex cases

---

This comprehensive guide provides the framework for successful CPT 77067 appeals across all major payers. Success depends on thorough documentation, payer-specific strategy, and persistent advocacy for evidence-based coverage decisions.